Molecular phenotype of CXCL12β 3'UTR G801A polymorphism (rs1801157) associated to HIV-1 disease progression

Carelia Garcia-Moruja, Patricia Rueda, Carmen Torres, José Alcamí, Francisco Luque, Antonio Caruz

Research output: Contribution to journalArticleResearchpeer-review

17 Citations (Scopus)


Objective: To investigate the molecular phenotype of the AIDS-onset delaying polymorphism in CXCL12β 3'UTR (rs1801157). Methods: The 3'UTRs of the CXCL12β isoform containing the A or G polymorphic variants were cloned downstream of the Luciferase gene under the control of the CXCL12 promoter. The plasmids were transfected in U373 and LC5 cells and the polymorphism phenotype was evaluated in terms of Luciferase activity and mRNA stability. Results: The 3'A genotype compared to 3'G leads to an increased luciferase activity in unstimulated and PMA+Ionomycin treated cells both in astrocytes (p = 0,0002, p = 0,02) and fibroblasts (p = 0,002, p = 0,03). The mRNA containing the 3'A variant have two-fold longer half-life compared to the 3'G variant (p = 6,99E-7). Conclusions: CXCL12β3'A polymorphism, previously associated with resistance to AIDS progression and other diseases, leads to increased levels of CXCL12 mRNA, the results presented here demonstrate that this effect is a consequence of an enhanced mRNA stability. Our data contribute to characterize the CXCL12 as a potential pharmacological target in AIDS, autoimmune diseases and cancer.

Original languageEnglish
Pages (from-to)384-389
Number of pages6
JournalCurrent HIV Research
Issue number4
Publication statusPublished - Jul 2009
Externally publishedYes


  • AIDS
  • CXCL12
  • mRNA stability
  • rs1801157
  • UTR

Cite this